Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis
- DOI
- 10.1016/j.clim.2026.110766
- Published
- 2026-12
- Container
- Clinical Immunology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clim.2026.110766,
title = {Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis},
author = {Darin T. Okuda and Benjamin J. Anderson and Sophia M. Taylor and Morgan C. Jones-McCreary and Katy W. Burgess and Crystal M. Wright and Jose R. Santoyo and Peter V. Sguigna and Olaf Stüve and Diem H. Tran and David Y. Light and Tatum M. Moog and Tom G. Punnen},
year = {2026},
journal = {Clinical Immunology},
doi = {10.1016/j.clim.2026.110766},
url = {https://doi.org/10.1016/j.clim.2026.110766}
}RIS
TY - JOUR TI - Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis AU - Darin T. Okuda AU - Benjamin J. Anderson AU - Sophia M. Taylor AU - Morgan C. Jones-McCreary AU - Katy W. Burgess AU - Crystal M. Wright AU - Jose R. Santoyo AU - Peter V. Sguigna AU - Olaf Stüve AU - Diem H. Tran AU - David Y. Light AU - Tatum M. Moog AU - Tom G. Punnen PY - 2026 JO - Clinical Immunology DO - 10.1016/j.clim.2026.110766 UR - https://doi.org/10.1016/j.clim.2026.110766 ER -
APA
Okuda, D. T., Anderson, B. J., Taylor, S. M., Jones-McCreary, M. C., Burgess, K. W., Wright, C. M., Santoyo, J. R., Sguigna, P. V., Stüve, O., Tran, D. H., Light, D. Y., Moog, T. M., & Punnen, T. G. (2026). Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis. Clinical Immunology. https://doi.org/10.1016/j.clim.2026.110766
Source records
- crossref · retrieved 2026-09-27T03:45:48.938Z